Abstract
SUMMARY: Cetuximab, a recombinant chimeric monoclonal antibody, has been successfully used in the treatment of the head and neck and colorectal cancers. We present a review of its mechanism of action, indications, side effects and economic issues, accompanied by a clinical example from our institution.
Cite
CITATION STYLE
APA
Bou-Assaly, W., & Mukherji, S. (2010). Cetuximab (Erbitux). American Journal of Neuroradiology, 31(4), 626–627. https://doi.org/10.3174/ajnr.A2054
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free